HCPCS Level IIdrugActive
J7208
Inj. jivi 1 iu
BETOS: O1E
Effective: 2019-07-01
Referenced in 5 policies
Description
Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Jivi
Manufacturer
Bayer HealthCare Pharmaceuticals Inc.
HCPCS Dosage
1 IU
Billing Units
1.0000
5
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.